A009300 Stock Overview
Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Sam-A Pharm. Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩15,700.00 |
| 52 Week High | ₩19,770.00 |
| 52 Week Low | ₩15,220.00 |
| Beta | 0.43 |
| 1 Month Change | -6.99% |
| 3 Month Change | -3.92% |
| 1 Year Change | -1.26% |
| 3 Year Change | 0% |
| 5 Year Change | -14.91% |
| Change since IPO | 108.25% |
Recent News & Updates
Recent updates
Key Things To Consider Before Buying Sam-A Pharm. Co., Ltd (KOSDAQ:009300) For Its Dividend
Apr 08
Is Sam-A Pharm (KOSDAQ:009300) A Risky Investment?
Mar 04How Much Did Sam-A Pharm's(KOSDAQ:009300) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 28
Four Days Left To Buy Sam-A Pharm. Co., Ltd (KOSDAQ:009300) Before The Ex-Dividend Date
Dec 24Sam-A Pharm. Co., Ltd (KOSDAQ:009300) Is Yielding 1.6% - But Is It A Buy?
Dec 07Shareholder Returns
| A009300 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -0.4% | 5.5% | 3.4% |
| 1Y | -1.3% | 8.1% | 7.1% |
Return vs Industry: A009300 underperformed the KR Pharmaceuticals industry which returned 8.1% over the past year.
Return vs Market: A009300 underperformed the KR Market which returned 7.1% over the past year.
Price Volatility
| A009300 volatility | |
|---|---|
| A009300 Average Weekly Movement | 3.0% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A009300 has not had significant price volatility in the past 3 months.
Volatility Over Time: A009300's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 295 | Heo Jun | www.samapharm.co.kr |
Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid concentration enhancement, endurance enhancement, and the supply of vitamins and minerals; and NOMA-F gummy, NOMA CHEWABLE tablet, and NOMA GOLD chewable tablet for growth promotion, enhancement of nutritional deficiency, and supply of vitamins.
Sam-A Pharm. Co., Ltd Fundamentals Summary
| A009300 fundamental statistics | |
|---|---|
| Market cap | ₩95.82b |
| Earnings (TTM) | ₩21.37b |
| Revenue (TTM) | ₩97.21b |
4.5x
P/E Ratio1.0x
P/S RatioIs A009300 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A009300 income statement (TTM) | |
|---|---|
| Revenue | ₩97.21b |
| Cost of Revenue | ₩35.59b |
| Gross Profit | ₩61.62b |
| Other Expenses | ₩40.25b |
| Earnings | ₩21.37b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.50k |
| Gross Margin | 63.39% |
| Net Profit Margin | 21.99% |
| Debt/Equity Ratio | 2.1% |
How did A009300 perform over the long term?
See historical performance and comparison